Avid Bioservices Inc (CDMO)

[sulaco]

IFU, Brekken begs to differ


I call BS on your BS.


The new understanding of the MOA and its position in the emerging field of oncologic immunotherapy, blows away your "same ol', same ol'" argument.


If Bavi were not recognized as the critical player it is in upstream checkpoint inhibition of PS, there's no reason to be here.

But there is, so we're here.


GLTAL!

Best,

Joe